ARCHIVE

• CROs Aim at Becoming Real Partners of Drug Firms: JCROA Chairman Mr Nakamura
  November 28, 2005

• Industry, Doctors, Patients, Gov't Exchange Opinions on Drugs
  November 28, 2005

• R&D NEWS IN BRIEF
  November 28, 2005

• AHA's Scientific Sessions 2005
  November 28, 2005

• REGULATORY NEWS IN BRIEF
  November 28, 2005

• Insurance Exemption Proposed by MOF Likely to Be Discarded: Reform Council
  November 28, 2005

• Health Minister Kawasaki Expresses Concern Over MOF's Proposals
  November 28, 2005

• Korosho to Require Nationwide Supply of Generics with a Full Range of Specifications
  November 28, 2005

• Generics' Brand Names Are Confusing: Prof. Sato of Chuo Univ.
  November 28, 2005

• BUSINESS NEWS IN BRIEF
  November 28, 2005

• Artz to Grow Despite Severer Competition: Mr Mizutani of Seikagaku Corp.
  November 28, 2005

• 1st 3 QTRS BUSINESS RESULTS
  November 28, 2005

• Pfizer Health Research Forum
  November 21, 2005

• Dainippon Sumitomo Enjoying "Smooth Start": Mr Miyatake
  November 21, 2005

• R&D NEWS IN BRIEF
  November 21, 2005

• Costs of Domestic Clinical Trials Remain Excessive: Mr Nakajima of JPMA
  November 21, 2005

• FPMAJ, JPMA Petition on FY2006 Budget, Taxation System
  November 21, 2005

• Drug Benefits Discussed by EAD Director Futagawa
  November 21, 2005

• JMA Objects that GPs Income Is Not as High as Reported by Korosho
  November 21, 2005

• Medical Fees Must Be Reduced by at Least 3%: MOF Council
  November 21, 2005

ページ

• « 先頭
• ‹ Prev
• …
• 435
• 436
• 437
• 438
• 439
• 440
• 441
• 442
• 443
• …
• Next ›
• 最終 »